Hypertension in Pregnancy NICE Guidelines

Slides:



Advertisements
Similar presentations
Leading Up to Delivery. Things to remember. Regular exercise eases your labor experience and helps you to return to pre-pregnancy weight Alcohol shouldnt.
Advertisements

Implementing NICE guidance
Screening test of Pregnancy
HYPERTENSION IN PREGNANCY
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Hypertension in Pregnancy
The ACOG Task force on hypertension in pregnancy
HYPERTENSIVE DISORDERS OF PREGNANCY Dr. Dianne MP Graham, MD, CCFP Based on Guidelines From SOGC ALARM Course & WHO Guide on Managing Complications in.
HYPERTENSIVE DISEASE IN PREGNANCY WITH ASSOCIATED NEONATAL OUTCOMES
Main function: Angelsounds monitors provide the required safety measures & convenience for pregnant women & their family members to listen to the heartbeat.
بسم الله الرّحمن الرّحیم Hypertension in pregnancy R.Mohammadjafari.MD.Gynecologist.
Pregnancy Outcome Prediction Study University Department of Obstetrics and Gynaecology; PI – Professor Gordon CS Smith BACKGROUND The current pattern of.
Northern England Strategic Clinical Network Conference
Growth Assessment Protocol
Best Start - Prenatal Education Program Prenatal Care.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
IN THE NAME OF GOD. CRITICALLY APPRAISED TOPIC If there is a Non-invasive prenatal testing for aneuploidies with low FPR at first trimester? If we can.
Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.
MANAGEMENT HTN IN PREGNANCY. DEFINITIONS The definition of gestational hypertension is somewhat controversial. Some clinicians therefore recommend close.
1.Royal College of Obstetricians and Gynaecologists. The Green Top Guidelines Number 21: The management of tubal pregnancy. (Online). Available from:
Hypertension in Pregnancy Updates: ACOG Task Force 2013.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
Underneath the surface Webinar, 23 July 2014 Tony Kofkin Director of Investigations NSW Health Care Complaints Commission.
Diseases and Conditions of Pregnancy pre-eclampsia once called toxemia –a pregnancy disease in which symptoms are –hypertension –protein in the urine –Swelling.
| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.
Objectives  Identify appropriate usage of BMP  Evaluate UCI Medicine Ward teams on usage of daily BMP and determining how often residents over-order.
Definition: EPH-Gestosis is a disease of disturbed gestation, i.e. a high risk pregnancy. If this disturbance is demonstrated by abnormal body water retention.
Strictly Private and Confidential 1 Welcome to Maternity Care Update for General Practitioners April 2013 Amanda Mansfield Consultant Midwife.
Is Antenatal Care Worthwhile? Max Brinsmead MB BS PhD May 2015.
UOG Journal Club: July 2013 Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis G. Pagani, F. D’Antonio,
THIRD TRIMESTER PROBLEMS Hypertension Small for dates Post-term pregnancy.
TEMPLATE DESIGN © Umbilical artery Pulsatility Index and different reference ranges: Does it really matter? Lo W., Mustafa.
Mamdouh Albaqumi, MD, FASN Nephrology Section Department of Medicine King Faisal Specialist Hospital Hypertension and CKD in the Pregnancy.
TIME OF DELIVERY IN HYPERTENSIVE DISORERS OF PREGNANCY Laleh Eslamian MD. Prof. of Obstet & Gynecol Perinatologist, Shariati hospital, TUMS.
TEMPLATE DESIGN © Reduced Fetal Movements as a Predictor of Fetal Compromise Dr. Meenu Sharma Lancashire Teaching Hospital.
TEMPLATE DESIGN © BackgroundResultsDiscussions and Conclusions Key and References REFERENCES RCOG Green Top Guideline.
HIGHER HUMAN BIOLOGY Unit 2 Physiology and Health 1. Ante-natal Screening.
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
Late onset IUGR managment S-Borna.MD, Perinatolgy Dep, Vali-e-Asr hospital,TUMS.
Induction of labour Implementing NICE guidance 2 nd edition – March 2012 NICE clinical guideline 70.
DR NOORZADEH fellowship of perinatology Shariati hospital
Hypertension in Pregnancy
Information and advice: the risks and benefits of vaginal birth, induction of labour and caesarean section if the baby has macrosomia.
Early warning signs Save lives Prepared by Ibrahim Shaheen.
 Prolonged pregnancy  Decreased fetal movements  Hypertension in pregnancy  Diabetes in pregnancy  Fetal growth restriction  Multiple gestation.
Management infant born with mother Chickenpox
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
Clinical features Abnormal vasculogenesis and angiogenesis and releasing of anti-angiogenic factors results in Vasospasm Endothelial dysfunction Etiology.
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
Hypertension Disorders in Pregnancy
UOG Journal Club: October 2017
Section 6: Management in primary care
HYPERTENSIVE DISORDERS OF PREGNANCY
Diabetes- pregnancy, labour and the puerperium guideline
Defining hypertension
Pre-eclampsia Matthew Beaumont.
Chronic Hypertension Monitoring
James M. Roberts, M.D., Leslie Myatt, Ph.D.,et al.
Tabassum Firoz MD MSc FRCPC University of British Columbia
A. Khan, V. R. N. Ramoutar, B. Bassaw
Dr Kirtan Krishna MS , DNB, Fellowship in Fetal Medicine
Antenatal care in Hyperglycemia in Pregnancy
The Utilization of Sequential Compression Devices Among Pregnant Women
(UOG Editor for Trainees)
Repeat fasting lipid profile to confirm in 1-2 weeks
Fetal Medicine Foundation fetal and neonatal population weight charts
UOG Journal Club: October 2018
Risk Factors for Adverse Birth Outcomes
Nat. Rev. Nephrol. doi: /nrneph
Patient H: changes in circulating sFlt-1 levels and corresponding parameters after two apheresis treatments. Patient H: changes in circulating sFlt-1 levels.
Presentation transcript:

Hypertension in Pregnancy NICE Guidelines with additional diagnostic test for the PARROT trial Mild hypertension BP up to 149/99 mmHg Do not admit to hospital. Do not treat hypertension. Measure BP no more than x1/wk Test for proteinuria at each visit Carry out routine antenatal blood tests. If presenting before 32/40, or at high risk of pre-eclampsia, test for proteinuria and measure BP x2/ wk. Moderate hypertension BP 150/100–159/109 mmHg Do not admit to hospital. Treat hypertension to keep BP <150/ 80–100 mmHg. Measure BP at least x2/ wk. Test for proteinuria at each visit Test kidney function, electrolytes, FBC, transaminases, bilirubin. No further blood tests if no subsequent proteinuria. Arrange fetal USS Severe hypertension BP ≥ 160/110 mmHg Admit to hospital until BP ≤159/109 mmHg and treat hypertension to keep BP < 150/80–100 mmHg. Measure BP at least x4/ day Test for proteinuria daily Test kidney function, electrolytes, FBC, transaminases, bilirubin at presentation & then weekly. Arrange fetal USS Continue care as in guidelines pathway; integrate additional information from PlGF test as shown below PlGF >100 NORMAL PlGF 12-100 LOW PlGF <12 VERY LOW CONTINUE WITH USUAL MANAGEMENT CONSIDER INCREASED SURVEILLANCE ASSESS AS PRE-ECLAMPSIA This protocol is an example used in the NICE medical technology guidance adoption support resource for PlGF- based testing to help diagnose suspected pre-eclampsia. It was not produced for or commissioned by NICE Algorithm version 3.0 Jan 2016 ©2016 King’s College London

PlGF >100 pg/ml NORMAL PlGF 12-100 pg/ml LOW PlGF <12 pg/ml VERY LOW Normal test result: suggestive that no placental dysfunction. Unlikely to progress to delivery within 14 days. What does it mean?: 98% of women who are in this green range will not need delivery for pre-eclampsia within 14 days. Median time to delivery: < 35 weeks: 62 days 35-37 weeks: 16 days Plan: continue with usual management. Abnormal test result – low: suggestive of placental dysfunction. Increased risk for preterm delivery. What does it mean? A PlGF test result <100 pg/ml will correctly identify 95-96% of women with pre-eclampsia who need delivery within 14 days. Median time to delivery: < 35 weeks: 23 days 35-37 weeks: 9 days Plan: consider increased surveillance (e.g. moving one step up on the NICE chart above), with regular monitoring and fetal ultrasound if indicated. Highly abnormal test result – very low: suggestive of severe placental dysfunction (i.e. placental ‘growth’ is very low). What does it mean? The red range highlights those at highest risk of preterm delivery, including delivery of an SGA infant. For women presenting before 35 weeks with PlGF <12 pg/ml, 94% will be delivered preterm. Median time to delivery: < 35 weeks: 9 days 35-37 weeks: 4 days Plan: consider as ‘pre-eclampsia’ (regardless of proteinuria) with admission for assessment, increased surveillance and fetal ultrasound if indicated. Chappell et al Circulation 2013 LOW OR VERY LOW PLGF RESULT IS NOT AN INDICATION FOR DELIVERY IN ITSELF Algorithm version 3.0 Jan 2016 ©2016 King’s College London